Insider · CIK 0001828859
Muhammad Asif Seemab
Files at PLCE (Childrens Place, Inc.). First filing -, latest -.
In brief
Muhammad Asif Seemab files SEC Form 4 as director and 10% owner at PLCE (Childrens Place, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Muhammad Asif Seemab has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | PLCE Childrens Place, Inc. | JOther Common Stockindirect: See Footnotes | -500,000 | $0.00 | $0 | 13,093,236 | Aug 13, 2026 |
| Aug 11, 2026 | PLCE Childrens Place, Inc. | AGrant or award Common Stock | +500,000 | $0.00 | $0 | 603,583 | Aug 13, 2026 |
| Jul 8, 2025 | PLCE Childrens Place, Inc. | JOther Common Stockindirect: See Footnotes | -103,583 | $0.00 | $0 | 13,593,236 | Jul 10, 2025 |
Questions about Muhammad Asif Seemab
Answered from the filings on this page, as of the latest one.
Is Muhammad Asif Seemab buying or selling?
Muhammad Asif Seemab has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Muhammad Asif Seemab's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Muhammad Asif Seemab has 0.
Where does Muhammad Asif Seemab file Form 4?
Muhammad Asif Seemab has filed Form 4 at PLCE (Childrens Place, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.